Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis

References

• Bolufer P, Barragan E, Collado M, et al. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 2006;30:1471–1491.
   PubMed Web of Science ®Google Scholar
• Lichtman MA. The stem cell in the pathogenesis and treatment of myelogenous leukemia: a perspective. Leukemia 2001;15:1489–1494.
   PubMed Web of Science ®Google Scholar
• Arinc E, Sen A. Effects of in vivo benzo(a)pyrene treatment on liver microsomal mixed-function oxidase activities of gilthead seabream (Sparus aurata). Comp Biochem Physiol Pharmacol Toxicol Endocrinol 1994;107:405–414.
   PubMedGoogle Scholar
• Arinc E, Adali O, Gencler-Ozkan AM. Induction of N- nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 2000;74:329–334.
   PubMed Web of Science ®Google Scholar
• Arinc E, Arslan S, Bozcaarmutlu A, et al. Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol 2007;45:107–118.
   PubMed Web of Science ®Google Scholar
• Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study. Cancer Epidemiol Biomarkers Prev 2000;9:563–566.
   PubMed Web of Science ®Google Scholar
• Nagai F, Hiyoshi Y, Sugimachi K, et al. Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol Pharm Bull 2002;25:383–385.
   PubMed Web of Science ®Google Scholar
• Kennedy RD, D’Andrea AD. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol 2006;24:3799–3808.
   PubMed Web of Science ®Google Scholar
• Chen C, Umezu K, Kolodner RD. Chromosomal rearrangements occur in S. cerevisiae rfa1 mutator mutants due to mutagenic lesions processed by double-strand-break repair. Mol Cell 1998;2:9–22.
   PubMed Web of Science ®Google Scholar
• Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002;23:687–696.
   PubMed Web of Science ®Google Scholar
• Johnson RD, Liu N, Jasin M. Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination. Nature 1999;401:397–399.
   PubMed Web of Science ®Google Scholar
• Bogliolo M, Cabre O, Callen E, et al. The Fanconi anaemia genome stability and tumour suppressor network. Mutagenesis 2002;17:529–538.
   PubMed Web of Science ®Google Scholar
• Vispe S, Defais M. Mammalian Rad51 protein: a RecA homologue with pleiotropic functions. Biochimie 1997;79:587–592.
   PubMed Web of Science ®Google Scholar
• Vispe S, Cazaux C, Lesca C, et al. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 1998;26: 2859–2864.
   PubMed Web of Science ®Google Scholar
• Kim PM, Allen C, Wagener BM, et al. Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. Nucleic Acids Res 2001;29:4352–4360.
   PubMed Web of Science ®Google Scholar
• Richardson C, Stark JM, Ommundsen M, et al. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene 2004;23:546–553.
   PubMedGoogle Scholar
• Levy-Lahad E, Lahad A, Eisenberg S, et al. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 2001;98:3232–3236.
   PubMed Web of Science ®Google Scholar
• Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604–608.
   PubMed Web of Science ®Google Scholar
• Winsey SL, Haldar NA, Marsh HP, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000;60:5612–5616.
   PubMed Web of Science ®Google Scholar
• Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562–567.
   PubMed Web of Science ®Google Scholar
• Bishop DK, Ear U, Bhattacharyya A, et al. Xrcc3 is required for assembly of Rad51 complexes in vivo. J Biol Chem 1998;273: 21482–21488.
   PubMed Web of Science ®Google Scholar
• Schild D, Lio YC, Collins DW, et al. Evidence for simultaneous protein interactions between human Rad51 paralogs. J Biol Chem 2000;275:16443–16449.
   PubMed Web of Science ®Google Scholar
• Masson JY, Stasiak AZ, Stasiak A, et al. Complex formation by the human RAD51C and XRCC3 recombination repair proteins. Proc Natl Acad Sci USA 2001;98:8440–8446.
   PubMed Web of Science ®Google Scholar
• Yamada NA, Hinz JM, Kopf VL, et al. XRCC3 ATPase activity is required for normal XRCC3-Rad51C complex dynamics and homologous recombination. J Biol Chem 2004;279:23250–23254.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Cochran WG. The comparison of percentages in matched samples. Biometrika 1950;37:256–266.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Berlin JA, Rennie D. Measuring the quality of trials: the quality of quality scales. JAMA 1999;282:1083–1085.
   PubMed Web of Science ®Google Scholar
• Liu L, Yang L, Mi YC, et al. [Relationship between RAD51-g135C and XRCC3-C241T polymorphisms and prognosis of inv (16)/ t(16;16) (CBFbeta-MYH11) acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi 2011;32:433–438.
   PubMedGoogle Scholar
• Erculj N, Faganel Kotnik B, Debeljak M, et al. DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia. J Cancer Res Clin Oncol 2012;138:1919–1930.
   PubMed Web of Science ®Google Scholar
• Liu L, Yang L, Zhang Y, et al. [Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia]. Zhonghua Yi Xue Za Zhi 2008;88:378–382.
   PubMedGoogle Scholar
• Kuptsova N, Kopecky KJ, Godwin J, et al. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 2007;109:3936–3944.
   PubMed Web of Science ®Google Scholar
• Diamond HR, Ornellas MH, Orfao A, et al. Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms. J Hematol Oncol 2011;4:39.
   PubMed Web of Science ®Google Scholar
• Seedhouse C, Russell N. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia. Br J Haematol 2007;137:513–529.
   PubMed Web of Science ®Google Scholar
• Chokkalingam AP, Bartley K, Wiemels JL, et al. Haplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 2011;22:1721–1730.
   PubMed Web of Science ®Google Scholar
• Jawad M, Seedhouse CH, Russell N, et al. Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia. Blood 2006; 108:3916–3918.
   PubMed Web of Science ®Google Scholar
• Boyd EM, Bench AJ, Vaghela KJ, et al. Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes. Leukemia 2009;23:1164–1167.
   Google Scholar
• Matullo G, Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006;27:997–1007.
   PubMed Web of Science ®Google Scholar
• Seedhouse C, Bainton R, Lewis M, et al. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002;100:3761–3766.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang MR, Zhang Y, et al. Relationship of RAD51G135C and XRCC3C241T gene polymorphisms with acute myeloid leukemia, myelodysplastic syndromes and karyotype abnormalities. Zhonghua Xue Ye Xue Za Zhi 2006;27:727–731.
   Google Scholar
• Yang L, Liu L, Mi YC, et al. [Relationship between RAD51-G135C/XRCC3-C241T polymorphisms and development of acute myeloid leukemia with recurrent chromosome translocation]. Zhonghua Xue Ye Xue Za Zhi 2011;32:299–303.
   PubMedGoogle Scholar
• Hamdy MS, El-Haddad AM, Bahaa El-Din NM, et al. RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia. J Investig Med 2011;59:1124–1130.
   PubMed Web of Science ®Google Scholar
• Bhatla D, Gerbing RB, Alonzo TA, et al. DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group. Leukemia 2008;22: 265–272.
   PubMed Web of Science ®Google Scholar
• Seedhouse C, Faulkner R, Ashraf N, et al. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 2004;10:2675–2680.
   PubMed Web of Science ®Google Scholar
• Voso MT, Fabiani E, D’Alo F, et al. Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol 2007;18:1523–1528.
   PubMed Web of Science ®Google Scholar
• Rollinson S, Smith AG, Allan JM, et al. RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. Leuk Res 2007;31:169–174.
   PubMed Web of Science ®Google Scholar
• Sorour A, Ayad MW, Kassem H. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers 2013;17:195–201.
   PubMed Web of Science ®Google Scholar
• Olinski R, Gackowski D, Foksinski M, et al. Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 2002; 33:192–200.
   PubMed Web of Science ®Google Scholar
• Tebbs RS, Zhao Y, Tucker JD, et al. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci USA 1995;92:6354–6358.
   PubMed Web of Science ®Google Scholar